Stocks
Assertio Holdings IncASRT
NASDAQHealthcarePharmaceuticals$23.50
Price as of · delayed, not real-time
A commercial-stage pharmaceutical company focused on the development and commercialization of therapies for pain management and other central nervous system disorders. Its lead product, Zipsor, is a non-steroidal anti-inflammatory drug, and the company also markets Indocin and Cambia. Investors track Assertio for its specialty pharmaceutical portfolio and its efforts to grow through acquisitions and partnerships.
52W Range: $8.61-$23.50
Congressional Interest in Assertio Holdings Inc (ASRT)
1 member of Congress has disclosed 1 trade in Assertio Holdings Inc (ASRT), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading ASRT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-01-26 | Kurt Schrader | sell | $1K-$15K |